Lantheus Holdings, Inc. (LNTH)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNasdaqGMUnited StatesUS5165441032
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Lantheus Holdings, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:14. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 08:00 | 1.33 | — | — | Upcoming |
| 05 Nov 2026 07:00 | 1.26 | 1.68 | +33.2% | Beat |
| 06 Aug 2026 07:00 | 1.30 | 1.55 | +18.9% | Beat |
| 07 May 2026 07:00 | 1.23 | 1.46 | +18.8% | Beat |
| 26 Feb 2026 07:00 | 1.17 | 1.67 | +42.9% | Beat |
| 06 Nov 2025 07:00 | 1.27 | 1.27 | +0.2% | In line |
| 06 Aug 2025 07:00 | 1.68 | 1.57 | -6.3% | Miss |
| 07 May 2025 07:00 | 1.65 | 1.53 | -7.5% | Miss |
| 26 Feb 2025 07:00 | 1.54 | 1.59 | +3.0% | Beat |
| 06 Nov 2024 07:00 | 1.56 | 1.70 | +9.1% | Beat |
| 31 Jul 2024 07:00 | 1.83 | 1.80 | -1.6% | Miss |
| 02 May 2024 07:00 | 1.54 | 1.69 | +9.5% | Beat |
| 22 Feb 2024 07:00 | 1.44 | 1.75 | +21.3% | Beat |
| 02 Nov 2023 07:00 | 1.32 | 1.47 | +11.2% | Beat |
| 03 Aug 2023 07:00 | 1.31 | 1.54 | +17.4% | Beat |
| 04 May 2023 07:00 | 1.29 | 1.47 | +13.7% | Beat |
| 23 Feb 2023 07:00 | 0.96 | 1.37 | +42.2% | Beat |
| 03 Nov 2022 07:00 | 0.83 | 0.99 | +19.3% | Beat |
| 04 Aug 2022 07:00 | 0.70 | 0.89 | +26.7% | Beat |
| 29 Apr 2022 07:00 | 0.46 | 0.97 | +110.9% | Beat |
| 24 Feb 2022 07:00 | 0.17 | 0.25 | +50.0% | Beat |
| 04 Nov 2021 07:00 | 0.06 | 0.08 | +26.3% | Beat |
| 28 Jul 2021 07:00 | 0.05 | 0.11 | +120.0% | Beat |
| 04 May 2021 07:00 | -0.01 | 0.05 | +600.0% | Beat |
| 25 Feb 2021 16:00 | 0.01 | 0.07 | +460.0% | Beat |
| 05 Nov 2020 07:00 | -0.06 | 0.04 | +170.6% | Beat |
| 30 Jul 2020 08:00 | 0.06 | 0.10 | +58.7% | Beat |
| 30 Apr 2020 07:00 | 0.29 | 0.36 | +24.1% | Beat |
| 25 Feb 2020 07:00 | 0.30 | 0.34 | +13.5% | Beat |
| 31 Oct 2019 07:00 | 0.21 | 0.28 | +31.8% | Beat |
| 25 Jul 2019 07:00 | 0.25 | 0.27 | +6.3% | Beat |
| 30 Apr 2019 07:00 | 0.25 | 0.25 | +0.8% | In line |
| 19 Feb 2019 16:00 | 0.14 | 0.24 | +74.6% | Beat |
| 30 Oct 2018 16:00 | 0.18 | 0.24 | +35.2% | Beat |
| 01 Aug 2018 16:00 | 0.22 | 0.26 | +18.2% | Beat |
| 02 May 2018 16:00 | 0.22 | 0.22 | -1.5% | Miss |
| 26 Feb 2018 16:00 | 0.20 | 0.12 | -38.6% | Miss |
| 02 Nov 2017 16:00 | 0.20 | 0.24 | +18.2% | Beat |
| 01 Aug 2017 16:00 | 0.23 | 0.42 | +86.4% | Beat |
| 02 May 2017 16:00 | 0.19 | 0.28 | +48.9% | Beat |
| 21 Feb 2017 16:00 | 0.13 | 0.18 | +41.4% | Beat |
| 01 Nov 2016 16:00 | 0.07 | 0.15 | +112.3% | Beat |
| 04 Aug 2016 16:00 | 0.06 | 0.24 | +315.2% | Beat |
| 03 May 2016 16:00 | 0.06 | 0.15 | +169.8% | Beat |
| 22 Feb 2016 16:00 | 0.05 | 0.13 | +146.8% | Beat |
| 04 Nov 2015 16:00 | 0.05 | 0.18 | +233.3% | Beat |
| 04 Aug 2015 16:00 | -0.14 | 0.05 | +136.6% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 1.5B | +0.5% | 233.6M | 15.2% | 3.41 | -21.8% | 348.6M |
| 2024 | 1.5B | +18.3% | 312.4M | 20.4% | 4.36 | -6.2% | 465.1M |
| 2023 | 1.3B | +38.6% | 326.7M | 25.2% | 4.65 | +1,062.5% | 258.7M |
| 2022 | 935.1M | — | 28.1M | 3.0% | 0.40 | — | 263.4M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 100.50 | 101.80 | 100.26 | 101.40 | +0.94% | 9,859,575 | |
| Oct 2026 | 99.52 | 100.50 | 99.52 | 100.46 | +0.93% | 21,613,000 | |
| Sep 2026 | 101.43 | 101.43 | 99.31 | 99.53 | -1.42% | 21,814,200 | |
| Aug 2026 | 102.65 | 102.90 | 99.97 | 100.96 | +1.32% | 43,972,600 | |
| Jul 2026 | 111.69 | 111.72 | 98.81 | 99.64 | -10.19% | 19,962,700 | |
| Jun 2026 | 98.79 | 111.86 | 95.00 | 110.94 | +11.72% | 21,022,900 | |
| May 2026 | 84.88 | 103.89 | 83.71 | 99.30 | +17.35% | 23,767,900 | |
| Apr 2026 | 76.41 | 85.26 | 74.64 | 84.62 | +11.56% | 14,387,100 | |
| Mar 2026 | 74.58 | 84.38 | 72.33 | 75.85 | +1.25% | 25,644,400 | |
| Feb 2026 | 66.91 | 80.91 | 63.45 | 74.91 | +11.94% | 17,469,200 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- PharmaLogic to Acquire Lantheus' CDMO Business and Springfield, New Jersey Manufacturing Facility (opens in a new tab) 09 Nov 2026 21:05
- PharmaLogic Holdings Agrees To Acquire Lantheus Holdings' CDMO Operations, Springfield Production Site; Financial Terms Not Disclosed (opens in a new tab) Benzinga · 09 Nov 2026 17:14
- Lantheus Holdings: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 05 Nov 2026 12:22
- Lantheus Welcomes CMS CY27 Final Rule Advancing Access to Diagnostic Radiopharmaceuticals (opens in a new tab) 05 Nov 2026 12:15
- Lantheus Reports Third Quarter 2026 Financial Results (opens in a new tab) 05 Nov 2026 12:00
- Lantheus Holdings Q3 Adj. EPS $1.68 Beats $1.24 Estimate, Sales $389.913M Beat $359.757M Estimate (opens in a new tab) Benzinga · 05 Nov 2026 08:57
- Lantheus Announces Presentation of Data at the 2026 Clinical Trials on Alzheimer’s Disease Annual Meeting (opens in a new tab) 02 Nov 2026 13:30
- Lantheus Holdings (LNTH) Could Be 7% Undervalued On BRAVNETSA Approval (opens in a new tab) Simply Wall St. · 26 Sep 2026 19:10
- Lantheus Holdings (LNTH) Stock May Be 14% Undervalued On FDA Approval (opens in a new tab) Simply Wall St. · 26 Sep 2026 03:08
- Strong Earnings, FDA Approval, and Takeover Interest Drive Lantheus Holdings’ (LNTH) Rally (opens in a new tab) Insider Monkey · 23 Sep 2026 15:14
- 3 Reasons LNTH is Risky and 1 Stock to Buy Instead (opens in a new tab) StockStory · 23 Sep 2026 14:57
- Curium acquisition of Lantheus backed by $5.375B of debt financing (opens in a new tab) Pitchbook · 26 Aug 2026 21:56
- Healthcare Equipment and Supplies Stocks Q2 Recap: Benchmarking Lantheus (NASDAQ:LNTH) (opens in a new tab) StockStory · 20 Aug 2026 21:03
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 101.25 USD
- Market cap
- 6.6B
- Exchange
- NasdaqGM
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow LNTH and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.